Yuki Gosei Kogyo Co., Ltd.

TSE:4531 Voorraadrapport

Marktkapitalisatie: JP¥5.7b

Yuki Gosei Kogyo Inkomsten in het verleden

Verleden criteriumcontroles 5/6

Yuki Gosei Kogyo has been growing earnings at an average annual rate of 42.5%, while the Chemicals industry saw earnings growing at 8.2% annually. Revenues have been growing at an average rate of 5.4% per year. Yuki Gosei Kogyo's return on equity is 7.7%, and it has net margins of 6.8%.

Belangrijke informatie

42.5%

Groei van de winst

42.5%

Groei van de winst per aandeel

Chemicals Groei van de industrie6.6%
Inkomstengroei5.4%
Rendement op eigen vermogen7.7%
Nettomarge6.8%
Laatste winstupdate30 Sep 2024

Recente prestatie-updates uit het verleden

We Think Yuki Gosei Kogyo's (TSE:4531) Healthy Earnings Might Be Conservative

May 22
We Think Yuki Gosei Kogyo's (TSE:4531) Healthy Earnings Might Be Conservative

Recent updates

We Think Yuki Gosei Kogyo's (TSE:4531) Healthy Earnings Might Be Conservative

May 22
We Think Yuki Gosei Kogyo's (TSE:4531) Healthy Earnings Might Be Conservative

Why Investors Shouldn't Be Surprised By Yuki Gosei Kogyo Co., Ltd.'s (TSE:4531) Low P/E

Feb 28
Why Investors Shouldn't Be Surprised By Yuki Gosei Kogyo Co., Ltd.'s (TSE:4531) Low P/E

Opbrengsten en kosten

Hoe Yuki Gosei Kogyo geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.

Inkomsten en omzetgeschiedenis

TSE:4531 Opbrengsten, kosten en inkomsten (JPY Millions )
DatumInkomstenInkomstenG+A UitgavenR&D-uitgaven
30 Sep 2414,3309721,439503
30 Jun 2413,2548281,406624
31 Mar 2412,9327761,425639
31 Dec 2312,7516341,446612
30 Sep 2312,3363381,438553
30 Jun 2312,6074741,498575
31 Mar 2312,8395561,503589
31 Dec 2213,0073101,574650
30 Sep 2213,4565501,598653
30 Jun 2212,9655251,557448
31 Mar 2212,3612481,524377
31 Dec 2112,0474321,470228
30 Sep 2110,8641871,405204
30 Jun 2111,0693451,386198
31 Mar 2111,0912881,360211
31 Dec 2010,117-561,338343
30 Sep 2010,831861,353337
30 Jun 2010,723-871,341434
31 Mar 2010,717-421,332629
31 Dec 1911,1251411,354549
30 Sep 1910,8872001,320530
30 Jun 1910,6202081,343466
31 Mar 1910,2721041,357345
31 Dec 189,8081151,327311
30 Sep 189,70551,349363
30 Jun 189,806191,343399
31 Mar 1810,0731251,371338
31 Dec 1710,3451961,415321
30 Sep 1710,6033221,431304
30 Jun 1710,5233811,410270
31 Mar 1710,3963551,384404
31 Dec 1610,1253261,373446
30 Sep 1610,0343021,369456
30 Jun 1610,3942391,379541
31 Mar 1610,5763501,362407
31 Dec 1510,3153621,332345
30 Sep 1510,4394541,302369
30 Jun 1510,2074611,300292
31 Mar 1510,0053301,319276
31 Dec 1410,095-171,318280
30 Sep 149,808-2101,312283
30 Jun 149,480-2351,299321
31 Mar 149,422531,289360
31 Dec 139,662371,278367

Kwaliteitswinsten: 4531 has high quality earnings.

Groeiende winstmarge: 4531's current net profit margins (6.8%) are higher than last year (2.7%).

Analyse vrije kasstroom versus winst

Analyse van de winstgroei in het verleden

Winsttrend: 4531's earnings have grown significantly by 42.5% per year over the past 5 years.

Versnelling van de groei: 4531's earnings growth over the past year (187.6%) exceeds its 5-year average (42.5% per year).

Winst versus industrie: 4531 earnings growth over the past year (187.6%) exceeded the Chemicals industry 12.3%.

Rendement op eigen vermogen

Hoge ROE: 4531's Return on Equity (7.7%) is considered low.

Rendement op activa

Rendement op geïnvesteerd vermogen

Ontdek sterk presterende bedrijven uit het verleden

7D

1Y

7D

1Y

7D

1Y